Literature DB >> 30936492

Translate less, prime better, to improve anti-tumor responses.

Marianne Burbage1, Marine Gros1, Sebastian Amigorena2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30936492     DOI： 10.1038/s41590-019-0371-8

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  1 in total

1.  Batf3-Dependent Genes Control Tumor Rejection Induced by Dendritic Cells Independently of Cross-Presentation.

Authors:  Derek J Theisen; Stephen T Ferris; Carlos G Briseño; Nicole Kretzer; Arifumi Iwata; Kenneth M Murphy; Theresa L Murphy
Journal:  Cancer Immunol Res       Date:  2018-11-27       Impact factor: 11.151
  1 in total
  4 in total

Review 1.  Emerging role of RNA modification N6-methyladenosine in immune evasion.

Authors:  Xin Lou; Juan-Juan Wang; Ya-Qing Wei; Jin-Jin Sun
Journal:  Cell Death Dis       Date:  2021-03-19       Impact factor: 8.469

Review 2.  YT521-B homology domain family proteins as N6-methyladenosine readers in tumors.

Authors:  Heng Yang; Chengyao Chiang; Qinhong Luo; Chunlan Chen; Junrong Huang; Lizhi Zhu; Duo Zheng
Journal:  Front Genet       Date:  2022-08-09       Impact factor: 4.772

Review 3.  The RNA modification N6-methyladenosine as a novel regulator of the immune system.

Authors:  Ziv Shulman; Noam Stern-Ginossar
Journal:  Nat Immunol       Date:  2020-04-13       Impact factor: 25.606

Review 4.  N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.

Authors:  Liting Guo; Hui Yang; Chenfei Zhou; Yan Shi; Lei Huang; Jun Zhang
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.